Cannabinoid treatment for autism: a proof-of-concept randomized trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoid treatment for autism: a proof-of-concept randomized trial
Authors
Keywords
-
Journal
Molecular Autism
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-03
DOI
10.1186/s13229-021-00420-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
- (2020) Cifelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
- (2020) Laura Fusar-Poli et al. Brain Sciences
- Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- (2019) Lihi Bar-Lev Schleider et al. Scientific Reports
- The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain
- (2019) Ethan B. Russo Frontiers in Plant Science
- Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
- (2019) Raquel Guerrero-Alba et al. Frontiers in Pharmacology
- Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
- (2019) Dana Barchel et al. Frontiers in Pharmacology
- Lower circulating endocannabinoid levels in children with autism spectrum disorder
- (2019) Adi Aran et al. Molecular Autism
- Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder
- (2019) Charlotte Marie Pretzsch et al. NEUROPSYCHOPHARMACOLOGY
- The “entourage effect”: Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders
- (2019) Sari Goldstein Ferber et al. Current Neuropharmacology
- Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
- (2019) Paulo Fleury-Teixeira et al. Frontiers in Neurology
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Sex specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling
- (2018) Francesca Melancia et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma anandamide concentrations are lower in children with autism spectrum disorder
- (2018) Debra S. Karhson et al. Molecular Autism
- Autism spectrum disorder
- (2018) Catherine Lord et al. LANCET
- Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism
- (2018) Suzanne Hosie et al. Frontiers in Cellular Neuroscience
- Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors
- (2018) Hanna J. Szkudlarek et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
- (2018) Brishna S. Kamal et al. Frontiers in Neuroscience
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
- (2017) Erica Zamberletti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treating a novel plasticity defect rescues episodic memory in Fragile X model mice
- (2017) W Wang et al. MOLECULAR PSYCHIATRY
- Autism, epilepsy, and synaptopathies: a not rare association
- (2017) Roberto Keller et al. NEUROLOGICAL SCIENCES
- Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
- (2017) Douglas L Boggs et al. NEUROPSYCHOPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endocannabinoid Signaling in the Control of Social Behavior
- (2017) Don Wei et al. TRENDS IN NEUROSCIENCES
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder
- (2016) Lawrence Scahill et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- Effect of Parent Training vs Parent Education on Behavioral Problems in Children With Autism Spectrum Disorder
- (2015) Karen Bearss et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
- (2014) Fabio Arturo Iannotti et al. ACS Chemical Neuroscience
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now